Effect of Steady-State Ambrisentan on the Pharmacokinetics of a Single Dose of the Oral Contraceptive Norethindrone (Norethisterone) 1 mg/Ethinylestradiol 35 μg in Healthy Subjects: An Open-Label, Single-Sequence, Single-Centre Study

Author： Spence Rebecca   Mandagere Arun   Walker Gennyne   Dufton Christopher   Boinpally Ramesh  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.30, Iss.5, 2010-05, pp. : 313-324

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Rifampicin (Rifampin) on the Pharmacokinetics and Safety of Ambrisentan in Healthy Subjects: A Single-Sequence, Open-Label Study

By Harrison Brooke  

Clinical Drug Investigation, Vol. 30, Iss. 12, 2010-12 ,pp. : 875-885

Adis International

Access to resources Recommend Favorite

Effect of Multiple Oral Doses of Linagliptin on the Steady-State Pharmacokinetics of a Combination Oral Contraceptive in Healthy Female Adults: An Open-Label, Two-Period, Fixed-Sequence, Multiple-Dose Study

By Friedrich Christian  

Clinical Drug Investigation, Vol. 31, Iss. 9, 2011-09 ,pp. : 643-653

Adis International

Access to resources Recommend Favorite

Effects of an Oral Contraceptive Containing Chlormadinone and Ethinylestradiol on Acne-Prone Skin of Women of Different Age Groups: An Open-Label, Single-Centre, Phase IV Study

By Kerscher Martina  

Clinical Drug Investigation, Vol. 28, Iss. 11, 2008-01 ,pp. : 703-711

Adis International

Access to resources Recommend Favorite

Steady-State Pharmacokinetics of Rivastigmine in Patients with Mild to Moderate Alzheimer's Disease Not Affected by Co-Administration of Memantine: An Open-Label, Crossover, Single-Centre Study

By Shua-Haim Joshua  

Clinical Drug Investigation, Vol. 28, Iss. 6, 2008-01 ,pp. : 361-374

Adis International

Access to resources Recommend Favorite

Dose Proportionality of Fentanyl Buccal Tablet in Doses Ranging from 600 to 1300 μg in Healthy Adult Subjects: A Randomized, Open-Label, Four-Period, Crossover, Single-Centre Study

By Darwish Mona  

Clinical Drug Investigation, Vol. 30, Iss. 6, 2010-06 ,pp. : 365-373

Adis International

Access to resources Recommend Favorite